People

The BSRBR-RA study is supported by a dedicated team based at the Biologic Studies Group at The University of Manchester.

Professor Kimme Hyrich is the Chief Investigator and the study is managed by Dr Kath Watson. They oversee the work of the project administrators, pharmacovigilance (drug safety) team and the researchers working with the data.

If you have any queries about the study, including eligibility and recruitment, please contact biologics.register@manchester.ac.uk or on 0161 275 1652.